Jorge Bermudez
Direktor/Vorstandsmitglied bei Drugs for Neglected Diseases initiative
Profil
Jorge Bermudez is currently the Director at Drugs for Neglected Diseases initiative and Vice President-Health Production & Innovation at Fundação Oswaldo Cruz.
He was previously the Executive Director at Unitaid from 2007 to 2011.
He received his undergraduate degree from Federal University of Rio de Janeiro in 1971 and his graduate degree from the same university in 1976.
Aktive Positionen von Jorge Bermudez
| Unternehmen | Position | Beginn |
|---|---|---|
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - |
| Fundação Oswaldo Cruz | Corporate Officer/Principal | 01.01.2011 |
Ehemalige bekannte Positionen von Jorge Bermudez
| Unternehmen | Position | Ende |
|---|---|---|
Unitaid
 Unitaid Miscellaneous Commercial ServicesCommercial Services Unitaid operates organization that invests in innovations to prevent, diagnose and treat HIV/AIDS. The company was founded in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Jorge Bermudez
| Federal University of Rio de Janeiro | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
Unitaid
Unitaid Miscellaneous Commercial ServicesCommercial Services Unitaid operates organization that invests in innovations to prevent, diagnose and treat HIV/AIDS. The company was founded in 2006 and is headquartered in Geneva, Switzerland. | Commercial Services |
